PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? (Q53542472)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

PET-CT vs contrast-enhanced CT: what is the role for each after chemoradiation for advanced oropharyngeal cancer? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Isabel Vilaseca González

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Amy Y Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Patricia A Hudgins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Ragheev Halkar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

487-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16619274%20AND%20SRC:MED&resulttype=core&format=json

Can positron emission tomography improve the quality of care for head-and-neck cancer patients?

19 January 2020

cites work

1 reference

Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?

21 January 2018

1 reference

Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

21 January 2018

1 reference

7 January 2021

Late effects of radiation therapy in the head and neck region

1 reference

7 January 2021

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

1 reference

7 January 2021

PET scanning in head and neck oncology: a review

1 reference

7 January 2021

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation

1 reference

7 January 2021

Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers

1 reference

7 January 2021

The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients

1 reference

7 January 2021

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

1 reference

7 January 2021

F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer

1 reference

7 January 2021

Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy

1 reference

7 January 2021

The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.

1 reference

7 January 2021

Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography

1 reference

7 January 2021

Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx

1 reference

7 January 2021

Positron emission tomography in the evaluation of laryngeal carcinoma

1 reference

7 January 2021

Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient

1 reference

7 January 2021

18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients

1 reference

7 January 2021

Uses and limitations of FDG positron emission tomography in patients with head and neck cancer

1 reference

7 January 2021

Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose

1 reference

7 January 2021

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

1 reference

7 January 2021

Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography

1 reference

7 January 2021

FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer

1 reference

7 January 2021

A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma

1 reference

7 January 2021

Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography

1 reference

7 January 2021

Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer

1 reference

7 January 2021

Surveillance for recurrent head and neck cancer using positron emission tomography

1 reference

7 January 2021